Fractalkine/CX3CL1: a potential new target for inflammatory diseases.

Overview of attention for article published in Molecular Interventions, November 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#18 of 178)
High Attention Score compared to outputs of the same age (91st percentile)

Mentioned by

blogs: 1 blog
twitter: 2 X users

patent: 4 patents

Readers on

mendeley: 269 Mendeley
citeulike: 1 CiteULike

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,204 followers.

RT @NextGenFinAdvic: @dannyday I don’t have time to watch this. But I used to be a scientist and am published on fractalkine, which I can s…

@dannyday I don’t have time to watch this. But I used to be a scientist and am published on fractalkine, which I can see must be discussed in this. Even similar slide to what I created and is published more than 10 years ago. Cool stuff. https://t.co/sf0Y…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.